Cardiometabolic Profiles and Treatment Trajectories of GLP ‐1 Receptor Agonist Users With Obstructive Sleep Apnea: Real‐World Evidence From a Large Private Healthcare Cohort in Poland

Documenti analoghi

• The extent and predictors of off‐label use of GLP ‐1 receptor agonists for weight loss management
  di: Zbigniew Siudak, et al.
  Pubblicazione: (2025)
• Interpreting Pregnancy Risk After GLP ‐1 Receptor Agonists Discontinuation
  di: Roberta Scairati, et al.
  Pubblicazione: (2026)
• Association of GLP ‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program
  di: Inyoung Hwang, et al.
  Pubblicazione: (2026)
• GLP ‐1 Receptor Agonists and Psychiatric Outcomes in Adolescents: A Systematic Review and Meta‐Analysis
  di: Cynthia F. X. C. A. Silva, et al.
  Pubblicazione: (2026)
• Safety of GLP ‐1 and Dual GLP ‐1/ GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes
  di: Lasin Ozbek, et al.
  Pubblicazione: (2026)